Latest news
Tarsus Pharmaceuticals (NASDAQ:TARS) Issues Earnings Results - MarketBeatMarketBeat · Sat, 08 Aug 2026 04:15:52 GMTTarsus Pharmaceuticals (TARS) Stock Can Revenue Momentum Outrun Rising Costs - simplywall.stsimplywall.st · Sat, 08 Aug 2026 01:11:15 GMTAmazon Pharmacy to Offer GLP-1 Delivery Service | PharmExec - Pharmaceutical ExecutivePharmaceutical Executive · Fri, 07 Aug 2026 18:02:55 GMTTarsus Pharmaceuticals Q2 Earnings Call Highlights - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 17:04:07 GMTMidday Stock Roundup: Karman Market Cap Surges on Earnings - ocbj.comocbj.com · Fri, 07 Aug 2026 16:30:20 GMTH.C. Wainwright Maintains Tarsus Pharmaceuticals(TARS.US) With Buy Rating, Maintains Target Price $88 - MoomooMoomoo · Fri, 07 Aug 2026 15:28:07 GMTTarsus secures USD 125m to fund Alkeus acquisition and expand eye care pipeline - AllSciAllSci · Fri, 07 Aug 2026 14:59:09 GMTMizuho Adjusts Tarsus Pharmaceuticals PT to $100 From $98, Maintains Outperform Rating - marketscreener.commarketscreener.com · Fri, 07 Aug 2026 14:46:25 GMT